38 phenotypes from 3 alleles in 4 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Tnfrsf13btm1Cmac/Tnfrsf13btm1Cmac Not Specified	enlarged spleen	J:91914
	normal immune system phenotype	J:92334
	increased B cell number	J:91914
Tnfrsf13btm1Rjb/Tnfrsf13btm1Rjb involves: 129X1/SvJ	abnormal class switch recombination	J:95288
	decreased IgA level	J:95288
	decreased IgE level	J:95288
	decreased IgG1 level	J:95288
Tnfrsf13btm1Rjb/Tnfrsf13btm1Rjb involves: 129X1/SvJ * C57BL/6	abnormal B cell activation	J:69474
	decreased IgA level	J:69474
	decreased IgM level	J:69474
	increased B cell number	J:69474
	increased B cell proliferation	J:69474
	increased spleen weight	J:69474
Tnfrsf13btm1Vmd/Tnfrsf13btm1Vmd involves: C57BL/6	abnormal immunoglobulin level	J:70172
	abnormal lymph node primary follicle morphology	J:70172, J:82331
	abnormal Peyer's patch follicle morphology	J:70172
	abnormal spleen morphology	J:70172
	abnormal spleen periarteriolar lymphoid sheath morphology	J:70172, J:82331
	abnormal spleen primary B follicle morphology	J:70172
	enlarged lymph nodes	J:70172, J:82331
	enlarged spleen	J:70172, J:82331
	glomerular crescent	J:82331
	glomerulonephritis	J:82331
	glomerulosclerosis	J:82331
	increased anti-double stranded DNA antibody level	J:82331
	increased anti-nuclear antigen antibody level	J:82331
	increased B cell number	J:70172, J:82331
	increased B cell proliferation	J:70172
	increased follicular B cell number	J:70172
	increased IgG1 level	J:70172
	increased leukemia incidence	J:82331
	increased marginal zone B cell number	J:70172
	increased mature B cell number	J:70172
	increased mesangial cell number	J:82331
	increased spleen germinal center size	J:70172
	increased spleen white pulp amount	J:70172
	increased transitional stage B cell number	J:70172
	increased urine protein level	J:82331
	kidney inflammation	J:82331
	liver inflammation	J:82331
	premature death	J:82331
	renal glomerular immunoglobulin deposits	J:82331
	renal glomerulus fibrosis	J:82331